#United States #New York #Class Action #Investor Rights #PROCEPT BioRobotics

Class Action Lawsuit Against PROCEPT BioRobotics

On September 9, 2026, the law firm Levi & Korsinsky, LLP, announced an alert for investors regarding a securities class action filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT). This lawsuit specifically targets shareholders who purchased the company's securities between February 28, 2024, and February 25, 2026. This notification is crucial for investors as it outlines eligibility for potential compensation regarding substantial financial losses suffered due to alleged misleading information released by PROCEPT BioRobotics.

Background of the Case

The class action lawsuit alleges that during the class period, PROCEPT BioRobotics made materially false or misleading statements related to their handpiece sales and recurring revenue figures. These misleading representations reportedly inflated the stock prices of PRCT shares well beyond their actual value. Following the public announcement on February 25, 2026, disclosing the actual sales figures and the end of a discount program, the stock price plummeted from approximately $100.00, resulting in over a 75% loss of value, dropping to under $25.00 per share.

Investors who bought shares during this timeframe may have experienced significant financial losses. The lawsuit's claims suggest that shareholders were misled about the true demand for PROCEPT's medical devices and the underlying financial health of the company. As stated by Joseph E. Levi, an attorney at Levi & Korsinsky, “When companies fail to disclose material information, shareholders may suffer significant losses.”

Key Points for Investors

Several important considerations arise for shareholders affected by this situation:

1. Eligible Shareholders: If you purchased PRCT shares within the specified period and incurred losses, you could be a class member entitled to recover damages.
2. No Lead Plaintiff Requirement: Investors do not need to seek a lead plaintiff appointment to participate in the recovery process, ensuring easier access for all affected investors to claim potential compensation.
3. Required Documentation: To solidify your claim, maintain accurate records of your trading activity, including purchase and sale dates along with quantities and prices.
4. Legal Process: The lawsuit was filed in the United States District Court for the Northern District of California, under the regulations of the Private Securities Litigation Reform Act of 1995.

Recent Developments

The lawsuit asserts that PROCEPT's previously disclosed information about handpiece sales was misleadingly inflated. The February 2026 announcement revealed factual data about procedure statistics that starkly contrasted previous company claims. According to the complaint, handpiece sales had outpaced actual procedures by 8% to 16% each quarter since the first quarter of 2023. This discrepancy raises questions about the trustworthiness of the company's financial communications and the sustainability of its business practices.

Understanding Your Rights

As the situation unfolds, shareholders must understand their rights related to this class action. Among the major queries raised by investors:

• - Can I still file a claim if I sold my shares? Yes, eligibility to recover losses pertains to the purchase period, not current ownership status.
• - Do I need to testify in court? Typically, class members are not required to attend court or provide testimony, simplifying participation.
• - What are the costs to join? There are no initial fees to join the lawsuit, as class actions are usually handled on a contingency basis, meaning any fees depend on the outcome of the case.

For more information or to inquire about your eligibility, impacted shareholders are encouraged to contact Levi & Korsinsky. They have a proven track record in fighting for shareholder rights and have successfully managed complex securities litigation cases to recover millions for investors nationwide.

In summary, if you are a shareholder of PROCEPT BioRobotics and believe you were misled regarding the company’s financial health, it is essential to assess your eligibility for this burgeoning class action lawsuit. Time is of the essence, as the deadline to register for lead plaintiffs is approaching on September 22, 2026.